Journal Logo

Management of Pediatrics Hydrocephalus: A Systematic review and metanalysis; on Endoscopic third Ventriculostomy (ETV), vs. ventriculoperitoneal shunt (VPS), Treatments and Postoperative Outcomes

Authors: Daniel Encarnacion-Santos[1]; Gennady Chmutin[1]; Egor Chmutin[1]; Emmanuel Batista-Geraldino[2]; Baraniko Eromanga[4]; Symbattym Bodanova[1]
Affiliations:
1. Federal State Autonomous Educational Institution of Higher Education Department of Neurosurgery "Peoples' of Friendship University, Moscow, Russia named after Patrice Lumumba" (RUDN) (RU) 2. Deparment of Neurosurgery, University teaching Hospital, Juan Pablo Pina, San Cristóbal, Dominican Republic 3. Tungaru Central Hospital Bikenibeu, Tarawa Rep of Kiribati
Daniel Encarnacion-Santos < Danielencarnacion2280@gmail.com>
Published Date: June 1, 2026
Keywords: Pediatrics, Hydrocephalus, Endoscopic third ventriculostomy (ETV), Ventriculoperitoneal shunt (VPS), Fenestration, Treatments, Outcomes

Abstract

Introduction: Inadequate passage of cerebrospinal fluid (CSF) through the points of production, such as the choroid plexus, absorption, and drainage into the dural venous sinus, causes hydrocephalus, which is characterized by a failure in CSF homeostasis and progressive active distension of the cerebral ventricles and the cerebral ventricular system. Methods: Using the PRISMA standards, R software, and Excel, we searched a number of databases, including ScienceDirect and PubMed/MEDLINE. Pediatric hydrocephalus, particular surgical methods, survival and fatality rates, as well as its physiology, pathology, and development, were among the search phrases used. Only research that was released in English between March 2000 and September 2025 Results: We distributed the N=3,119 pediatric hydrocephalus patients that we identified in our systematic evaluation in Table 1. N = 1728 patients (55%) and N = 948 (30%) underwent endoscopic procedures. VP-shunt N = 765 (24%). In contrast, Table 2 shows N=1391 patients (44%). ETV/VP shunt; N = 474 (15%). ETV/CPC; N = 766 (24%). In conclusion: Conclusion: Endoscopic third ventriculostomy (ETV) and choroid plexus cauterization (CPC) are combined operations used to treat hydrocephalus in children. These treatments range from straightforward Kocher point stenting to intricate shunt systems. The normal head circumference can be controlled to some extent by using a single decision to regulate the flow of cerebrospinal fluid (CSF).

Body

INTRODUCTION

Hydrocephalus is defined as a failure in cerebrospinal fluid (CSF) homeostasis and the progressive active distension of the ventricles and the cerebral ventricular system resulting from inadequate passage of CSF through the points of production, such as the choroid plexus, absorption, and drainage into the dural venous sinus. Therefore, infants with hydrocephalus tend to have an increased head circumference and may present with signs and symptoms of intracranial pressure. [1]. A canine experiment conducted by Walter Dandy in the mid-19th and early 20th centuries on obstructive hydrocephalus using phenolsulfonphthalein led to a more up-to-date understanding of communicating and non-communicating hydrocephalus. Although Hippocrates reported the term "water" in macrocephalic children, hydrocephalus itself was first described in the writings of Celsus, between 25 BC and 50 AD. [2]. Epidemiologically, approximately 400,000 new cases of pediatric hydrocephalus develop worldwide each year, with over 80% of these cases occurring in low- to middle-income countries [3]. Hydrocephalus is caused by neural tube defects, and up to 85% of children may be born with myelomeningocele and/or spina bifida-like myelomeningocele [4]. Endoscopic third ventriculostomy (ETV) involves fenestrating the floor of the third ventricle and diverting cerebrospinal fluid to the basal cisterns. When combined with choroid plexus cauterization (CPC-ETV), it is indicated in children under 2 years of age, where ETV alone carries a poor prognosis [5]. Figure 1 shows a) ETV for pediatric patients with hydrocephalus and fenestration of the third ventricle. b) VP-shunt: detailed components by structure and function for hydrocephalus drainage and external program, (ICP) measure of a Codman-Hakim shunt device. The aim of this systematic review is to analyze ETV vs. ventriculoperitoneal shunt (VPS) treatments and postoperative outcomes

Materials and Methods

Search Strategy

In our systematic review, we followed the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). We focused on the treatment of pediatric hydrocephalus, specifically endoscopic third-trimester ventriculostomy (ETV) versus ventriculoperitoneal shunt (VPS). We examined the results of postoperative studies with treatment modalities and effective management of hydrocephalus. A search was conducted in various databases, including ScienceDirect and PubMed/MEDLINE, using the PRISMA guidelines, R software, and Excel. Search terms included pediatric hydrocephalus, specific surgical techniques, survival and mortality rates, as well as its physiology, pathology, and development. Only studies published in English between March 2000 and September 2025 were included. The PICO framework (Population, Intervention, Comparison, and Outcomes) was used to define the study population, focusing on patients between 1 month and under 17 years of age with ventricular expansion and associated symptoms, diagnosed by imaging studies (Figure 2).

Search Strategy

The search strategy incorporated MeSH (Medical Subject Headings) terms related to pediatric hydrocephalus with myelomeningocele, third ventricle endoscopy, and VP-shunts. ( "Hydrocephalus/blood"[Mesh] OR "Hydrocephalus/cerebrospinal fluid"[Mesh] OR "Hydrocephalus/classification"[Mesh] OR "Hydrocephalus/complications"[Mesh] OR "Hydrocephalus/congenital"[Mesh] OR "Hydrocephalus/diagnosis"[Mesh] OR "Hydrocephalus/diagnostic imaging"[Mesh] OR "Hydrocephalus/diet therapy"[Mesh] OR "Hydrocephalus/drug therapy"[Mesh] OR "Hydrocephalus/embryology"[Mesh] OR "Hydrocephalus/epidemiology"[Mesh] OR "Hydrocephalus/etiology"[Mesh] OR "Hydrocephalus/genetics"[Mesh] OR "Hydrocephalus/history"[Mesh] OR "Hydrocephalus/immunology"[Mesh] OR "Hydrocephalus/metabolism"[Mesh] OR "Hydrocephalus/microbiology"[Mesh] OR "Hydrocephalus/mortality"[Mesh] OR "Hydrocephalus/parasitology"[Mesh] OR "Hydrocephalus/pathology"[Mesh] OR "Hydrocephalus/physiopathology"[Mesh] OR "Hydrocephalus/prevention and control"[Mesh] OR "Hydrocephalus/psychology"[Mesh] OR "Hydrocephalus/radiotherapy"[Mesh] OR "Hydrocephalus/surgery"[Mesh] OR "Hydrocephalus/therapy"[Mesh] ) Keywords: Other keywords include "hydrocephalus in children," "Endoscopic third ventriculostomy (ETV)," "VP-shunt," "Fenestration," "Diagnosis," "Neuroimaging," "Morbidity," and "Mortality."

Inclusion and exclusion criteria

Inclusion criteria: Age range: children under 1 month to under 17 years. Infant patients with congenital hydrocephalus associated with other pathologies such as myelomeningocele or Chiari malformation. Incidence, morbidity, and mortality of hydrocephalus in pediatric patients. Surgical and postoperative neurological outcomes of congenital and non-congenital hydrocephalus in the pediatric population, including obstructive hydrocephalus associated with posterior fossa tumors. Risk factors affecting children with hydrocephalus in terms of etiology, genetics, histology, and pathogenesis. Management of pediatric hydrocephalus, including diagnosis, neuroimaging (CT and MRI), and surgical procedures such as endoscopic third ventriculostomy (ETV) fenestration and ventriculoperitoneal shunt (VP shunt). Exclusion criteria: Studies of non-pediatric hydrocephalus or studies not in English were excluded, as were related publications that did not meet the inclusion criteria, those with abstract findings, and patients with myelomeningocele and without hydrocephalus.

Data and Analysis

We collected all data from the included studies related to various aspects of congenital obstructive hydrocephalus, including diagnosis, management, and treatment. We examined and evaluated factors influencing the presence of symptoms, hydrocephalus, and intraventricular hemorrhages, which can affect the lateral ventricles (herniation, blockage, and cerebrospinal fluid accumulation), as well as head circumference. Surgical treatment and management are focused on fenestration. Surgical techniques were also thoroughly reviewed due to their high mortality and survival rates and the causes of postoperative infections and/or the presence of epilepsy in cases of tumor mass in patients with ventricular expansion of accumulated CSF, considering its location, size, and shape for its removal. We extracted data using several standardized systems and rigorously analyzed them with research manuscripts relevant to this review. Once the data were compiled from detailed information for studies, we included demographic characteristics, interventions, and control parameters in comparative studies, as well as authorship, year of publication, and study design. Our data analysis plan was redefined before the start of data collection. Also using the R and Excel programs, we began with all aspects related to congenital hydrocephalus, including pediatric statistical studies for hydrocephalus management. This review used and analyzed the necessary statistics, including a forest plot, funnel plot, and 95% confidence interval, to determine heterogeneity and p-values and the magnitude of hydrocephalus in children.

Risk of Bias Assessment

We sought to ensure the results of the methodological search and assessed the quality of all included studies through systematic reviews and meta-analyses. The risk of bias for each study was determined using standard tools, according to the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). R Software Manager 5.4. The risk of bias can be found due to the intervention design and blinding of outcomes, which is key to ensuring the validity of the outcome assessment. According to the assessment, non-randomized studies presented a relatively high risk of bias, mainly related to participant selection with appropriate tools for bias assessment (Supplementary material).

Statistical analysis:

Our statistical analysis relied on data generated using R Software Manager 5.4 and Microsoft Excel. Data presentation: Results are presented as mean ± standard deviation (SD). In a comparative analysis, we included the comparative studies "Management of hydrocephalus in pediatric patients with Endoscopic Third Ventriculostomy (ETV) and Ventriculoperitoneal Shunt (VPS), Treatments and Postoperative Outcomes," surgical approach, postoperative outcomes, and survival. Statistical significance: A p < 0.05 was considered statistically significant. Effect measures: Mean differences and likelihood ratios were calculated for the observed outcomes. Model selection: We used random-effects models to estimate the measures of the outcomes of the individual studies and to bolster the calculations of the systematic review or meta-analysis.

Results

In our systematic review, we found a total of N=3,119 pediatric patients with hydrocephalus, which we distributed in Supplementary Table 1 [7,8,9,10,11,12,13,14,15,16,17,18]. N=1728 patients, (55%), with endoscopic procedure N=948, (30%). VP-shunt N=765. (24%). While in Supplementary Table 2 [19,20,21,22,23,24,25,26,27,28,29,30], N=1391 patients (44%). ETV/VP shunt; N=474, (15%). ETV/CPC; N=766 (24%). Heterogeneity was assessed as follows: Chi² = 17.96, df = 11, P < 0.08 vs. I² = 39%, test for overall effect: Z = 1.24, P = 0.21; Tau² = 0.01; Chi² = 20.13, df = 11, P < 0.04; I² = 45%, confidence interval test for overall effect: Z = 0.91, P = 0.72, P < 0.36. Tau2; 0.00; Chi² = 20.00, df = 11, P = 0.05; vs. I² = 45%, test for overall effect: Z = 1.09, P = 0.27. In a randomized controlled trial of 70 preterm infants aged 24 to 34 weeks with progressive enlargement of the cerebral ventricles, only 34 infants were assigned to irrigation and fibrinolytic therapy following intraventricular hemorrhage to remove blood and cytokines. Two shunts failed, requiring 13 revision surgeries (44%). Only 36 were evaluated with standard therapy, resulting in only 5 shunt failures. Only 14 infants underwent revision surgery (50%), while 12 infants underwent revision surgery (25%), a difference that was not statistically significant. Only 3 patients (8%) experienced secondary intraventricular hemorrhage, increasing the risk of subsequent shunt surgery and the need for more blood transfusions. Therefore, there was no reduction in the number of surgeries or mortality associated with shunt surgery. [6]. Figure 3 shows graphic representation of pediatric patients with hydrocephalus and surgical treatment, while figure 4 shows graphics of hydrocephalus studies and surgical interventions

Management of Endoscpic Third Ventriculostomy (ETV) for Hydrocephalus

To perform Endoscopic Third Ventricle Surgery and avoid the placement of a pulmonary venous shunt, a thorough understanding of the classic pathophysiology is essential, involving three well-known factors: cerebrospinal fluid (CSF) production, circulation, and absorption. Some concepts are based on seven factors, including CSF production, pulsatility, primary and secondary CSF pathways, absorption, venous flow, and respiration; these factors may have varying degrees of relevance in each individual hydrocephalic condition. The management of ETV focuses on resolving CSF pathologies and pulsatility. Therefore, the primary objective is to restore CSF communication between a ventricle and the subarachnoid space while simultaneously reducing stress pulsatility following increased ventricular wall distensibility or expansion. [31].

Congenital Hydrocephal

Congenital hydrocephalus usually presents in utero between the 3rd and 4th week of gestation. The formation of the ventricular system and amniotic fluid begins before the neural tube closes. While the lateral ventricles begin to develop during the fifth week of gestation, the fourth cerebral ventricle develops around the 8th week of gestation, along with the choroid villi. [32]. The fourth ventricle begins producing fluid around the 22nd week of gestation. [33]. The ventricles are lined by ependymal cells, which embryonically derive from radial glia and can be classified into multiciliated ependymal cells (E1 cells), which are active in the flow of cerebrospinal fluid (CSF) across the ventricular wall, and ciliated ependymal cells (E2 cells). and the E3 cell uniciliate, which covers the signaling of its maturation of the ciliated ependyma in the middle of its gestation and will be in full maturation 6 months after birth. [34].

Endoscopic Aqueductoplasty (EA)

EA is a means of restoring the physiological dynamics of cerebrospinal fluid (CSF). This procedure offers an alternative to the endoscopic third ventriculostomy surgery (ETV), as it avoids the risk of severe arterial bleeding. EA has been performed in cases of membranous occlusion, frequently showing a type of failure. [35]. A contributing factor to closure with reduced CSF flow is aqueductal closure through the stoma after ETV, accounting for approximately 50% of cases. Aqueductal aqueductal occlusion is considered a high-risk procedure for injury to structures such as the midbrain. Neurological deficits, such as oculomotor or trochlear nerve palsy, as well as Parinaud's syndrome and periaqueductal syndrome, are also associated with EA. Long-term ETV is more successful with less risk in cases of segmental membranous occlusion, including tumor-related occlusion, of the aqueduct. [36]. An exception is patients with isolation of the fourth ventricle and those with post-infectious and post-hemorrhagic hydrocephalus during the first year. Even after shunt placement, complicated drainage with aqueductal stenosis can occur. Aqueductoplasty can establish communication between the cerebrospinal fluid and the ventricular compartment, but stenting is necessary to maintain an open pathway. Aqueductoplasty, combined with stenting, is the endoscopic treatment method for isolated fourth ventricles. [37,38,39].

VP-shunt complications

VP- shunt disconnection: During surgery or procedures, some CSF shunts are structured with several separate components. If one of these components becomes disconnected, it can cause a failure. This can occur suddenly, perhaps after placement and/or during surgery. All components of the multi-component shunt system are at imminent risk of disconnection, as the catheters are fully inserted into these connectors. If the knots are poorly tied, disconnection can incorrectly secure the connection points. An example of shunt migration is a spring-loaded shunt system, as the catheters used are coated with polyvinylpyrrolidone, which is prone to excessive migration of the ventricular catheter. The hydrogel catheter lubricant likely increases the propulsion of the shunt valve at the connection point. These disconnections lead to an obstruction of cerebrospinal fluid flow, resulting in hydrocephalus. [40]. Migration: As the child grows, the catheter may retract or move from its initial location, creating a blockage of CSF drainage. This catheter migration, whether proximal or distal, can cause shunt failure after successful placement. This migration phenomenon can occur in both the proximal catheter, as the ventricle retracts, and in the distal catheter, such as in the cardiac atrium, the pleural space, and the peritoneum. Migration is also attributed to the removal of the catheter tip from the ventricle, as the head tends to grow, although this is not frequent. In children, by placing the catheter tip at the appropriate depth, the original procedure will remain in place until adulthood. Once the distal shunt, such as the valve, is established, it can become anchored as the infant grows; with traction from the distal structures, the intraventricular catheter can be pulled out of the ventricles directly into the brain parenchyma, obstructing the catheter's entry and blocking the flow of cerebrospinal fluid (CSF). The steering system has right-angle connectors called Rickham reservoirs, which resist proximal catheter migration. Therefore, diagnosis of this migration will be achieved through transverse imaging studies that will show the migration of the catheter tip from the ventricle. During the procedure, surgical replacement of the ventricular catheter will be performed if migration is present. We will proceed to suture the proximal catheter as a preventative measure and the valve to the pericranium, anchoring it as a system around the trephined orifice. [41]. Ventricular Shunt overdrainage: When decompression of the ventricular system occurs, and consequently, when pressure drops from extra-axial convexities or subdural hematomas, an overdrainage complication can develop in a functional shunt, draining more cerebrospinal fluid (CSF) than is optimal for the patient. [42]. This chronic overdrainage is considered an underlying cause of slit-ventilation syndrome, which may be related to the siphoning effect of the distal catheter. CSF siphoning occurs due to the gravitational force acting on the fluid column within the distal catheter. [43,44]. This siphoning can end up in the skull and is exacerbated by an upright posture. In VA and VPL shunts, a section created by intermittent negative ambient pressure at the distal end of the catheter will be exacerbated by the siphoning effect. [45]. Clinical and endoscopic studies from the University of Wisconsin in patients with chronic shunts have hypothesized that obstructions tend to recur in the proximal shunt, with complications resulting from chronic drainage syndrome that may go undetected for years. [46]. We will note the investments and significant efforts in developing updated and improved shunt valves and/or anti-siphon devices to address both acute and chronic complications of overdrainage and the distal catheter effect. However, the use of lumboperitoneal shunts in patients with ventricular overdrainage syndrome shows promise in reducing shunt failures. [47,48]. A recent prospective randomized controlled trial of post-infectious hydrocephalus (PIH) compared external ventricular drainage (EVD) and ventriculosubgaleal shunt (VVS) for treatment, hoping for cerebrospinal fluid (CSF) clearance for shunt placement via ventriculoperitoneal shunt. The study included 42 cases divided into two groups: 21 patients in group A (VVS) and 21 patients in group B (external ventricular drainage). This study showed a significant difference in the number of patients admitted to the pediatric intensive care unit (PICU) until the resolution of the infection, with the external ventricular drainage group having a higher rate of admission. However, there was no difference in complications, although mortality rates were similar. [49].

Discussion

Patients with large CSF volumes typically undergo a procedure with VPS. Patients with subdural collections often present with cognitive problems and smaller brain volumes, but mortality does not vary. Although some studies suggest that subdural collections are due to brain atrophy with a thin cortical mantle, CSF volume was not related to age and sex preoperatively; on the contrary, it was related to higher rates of subdural collection volumes. [11,12]. A recent randomized, prospective, comprehensive controlled study conducted on 158 five-year-old children, assessed using the Mark 2 health index (HUI-2), questioned the results compared through covariance with adjustment of baseline variables between age at surgery and initial developmental status of hydrocephalus (HOQ), as a measure of quality of life. Initially, of 78 patients, 19 were treated with shunting and 61 with endovascular anastomosis (EVA), at a mean age of 62.1 months (SD 6.3). The mean 5-year HUI-2 score was 0.90 (SD 0.19) for EVA and 0.94 (SD 0.10) for shunting (p = 0.21). The mean 5-year HOQ score was 0.81 (SD 0.15) for EVA and 0.85 (SD 0.12) for shunting (p = 0.42). Therefore, they believe that overall health status is high, with no significant difference in quality of life observed between the two surgical types in infants treated for aqueductal stenosis. [11,12]. The gross brain volume indicates that smaller brain volumes are normalized between 12-24 months without reflecting the absolute loss of volume. [13]. Arynchyna-Smith et al. proposed a revision study of (ETV) after the failure of (ETV+CPC) in children. The revision ETV showed a success rate of 29% of patients, a lower rate than the initial ETV+CPC. None of the patients presented with neurological deficits, infected wounds, or diabetes during the revision ETV. However, there was a significant difference between the two groups by age: older patients in the ETV group had a different success rate than those in the ETV+CPC group, as shown by a difference in ventricular size as measured by focal heart rate monitoring. [17]. Surgical Techniques for Subgaleal Ventricular Insertion Before placing the patient in the supine position, we must observe the coronal sutures and try to locate the Kocher point for insertion of the ventricular catheter. It is also extremely important not to restrain the thin skin of premature infants throughout the procedure. First, we must place the ventricular catheter in the frontal horn. Next, this ventricular catheter will be connected to a reservoir, using a right-angle connector, on a short, closed-end tube with slots, establishing unidirectional flow from both the ventricle and the subgaleal pouch. [50]. If the reservoir is not used, the tube will be fixed to the periosteum with a suture to prevent the catheter from migrating into the lateral ventricle; to prevent this, the reservoir must be used. Then, a subgaleal pouch will be created by blunt dissection with the fingers or with blunt-tipped Metz scissors with curved ends. [51]. Once dissected, care must be taken to avoid dissecting the subgaleal space too superficially or too deeply. Since larger subgaleal pouches tend to prolong the subgaleal ventricle shunt, the dissection should always be lateral, towards the ear, then over the occiput (but not the forehead), carefully approaching the midline to avoid skin perforation. The subgaleal catheter will be placed to drain into the pouch, and the wounds will be closed in two layers. The effectiveness of the subgaleal ventricle shunt will be assessed by the reduction in head circumference, the softening of the anterior fontanelle, and the reduction in ventricular size, observed with cranial ultrasound and other imaging studies. If the subgaleal pouch is tense anteriorly in a soft, fluctuant manner, with subgaleal fluid, cranial imaging studies are recommended to confirm ventricular enlargement. [52]. When a shunt fails, endoscopic third ventriculostomy (ETV) is recommended. When shunt dysfunction and recurring infection occur, ETV is recommended as an adjuvant treatment. [54,55,53]. This method works well, although it is not as good as ventriculoperitoneal shunting in situations of fourth ventricle obstruction and endoscopic transforaminal transventricular foraminoplasty with flexibility of the foramina of Magendie and Luschka in an open suboccipital craniotomy. [57,58,56]. Additionally, ETV is often helpful in situations of fourth ventricle neurocysticercosis. [60,59]. A combination rigid-flexible endoscope will be helpful for the endoscopic transluminal endoscopy (ETV) and biopsy, which will be carried out via a single burr hole. [62,61]. ETV will be recommended in cases of hydrocephalus with posterior fossa lesions, such as cerebellar infarction with a cerebellopontine angle tumor and no severe brainstem compression. (63). The diagnosis of basal meningitis will also be aided by a biopsy of the basal cisterns. (64). (TVE); is helpful in removing brain clots from intraventricular hemorrhages. [66,65]. Additionally, full-term newborns with normal birth weight and patients with Chiari type 1 deformities, whether or not they have syringomyelia, benefit greatly from it. [68,67]. Limitations and Future Directions Cerebrospinal fluid (CSF) occlusion in the aqueduct is regarded as a high-risk procedure for harm to tissues including the midbrain, and endoscopic third ventriculostomy (VTE) accounts for about 50% of cases. These kinds of pathology are also linked to neurological impairments such oculomotor or trochlear nerve palsy, as well as Parinaud's syndrome and periaqueductal syndrome. Overdrainage, proximal and distal shunt blockage, catheter breakage or migration, and when to use third ventricle endoscopy are all limits to take into account. Revisions are also required, but deciding whether to fix the shunt or just replace it with a new ventricular system is crucial. Any component that is positioned incorrectly may result in drainage failure, necessitating either third ventricle endoscopy or revision of the pulmonary venous shunt. Although the usage of new shunt systems is increasing, the surgeon's experience must still be taken into account to prevent damaging vascular or anatomical structures. Although some research is still continuing, hydrocephalus has previously been treated with new stem cell procedures. Neuronavigation has shown promise in the assessment and treatment of burr holes and in cases of tumor-induced obstructive hydrocephalus.

Conclusion

Endoscopic third ventriculostomy (ETV) and choroid plexus cauterization (CPC) are combined operations used to treat hydrocephalus in children. These treatments range from straightforward Kocher point stenting to intricate shunt systems. Cerebrospinal fluid (CSF) flow is managed with a single choice, which permits some control over normal head circumference. Ventriculoperitoneal shunting and various treatments to remove extra CSF result from overdrainage. This review illustrates the path from the implantation of a ventriculoperitoneal shunt to the choice to carry out a third ventriculoscopy in order to manage excess CSF and avoid childhood hydrocephalus symptoms. Management is usually simple and short-lived, but when postoperative failure happens, it becomes complicated, necessitating adjustments to retract or reposition the shunt and, eventually, the choice to undergo a third ventriculoscopy. This study shows that every part of the shunt needs to be exact in order to prevent failure, which will result in excess fluid and, ultimately, chronic hydrocephalus. Intraventricular bleeding and consequences, such as midbrain lesions and lesions of other anatomical structures, might result from the enlargement of the lateral ventricles with cranial growth. This study demonstrates that while there are variations in the infants' age and sex, there are no variations in the complications, and surgery is nearly always the only treatment for hydrocephalus symptoms.

Figures

a) ETV for pediatric patients with hydrocephalus and fenestration of the third ventricle. b) VP-shunt: detailed components by structure and function for hydrocephalus drainage and external program, (ICP)  measure  of a Codman-Hakim shunt device.
a) ETV for pediatric patients with hydrocephalus and fenestration of the third ventricle. b) VP-shunt: detailed components by structure and function for hydrocephalus drainage and external program, (ICP) measure of a Codman-Hakim shunt device.
PRISMA on Pediatrics Hydrocephalus, ETV vs. VP-shunt
PRISMA on Pediatrics Hydrocephalus, ETV vs. VP-shunt
Graphic representation of pediatric patients with hydrocephalus and surgical treatment.
Graphic representation of pediatric patients with hydrocephalus and surgical treatment.
Graphics of hydrocephalus studies and surgical interventions
Graphics of hydrocephalus studies and surgical interventions

References

1. Kahle KT, Klinge PM, Koschnitzky JE, Kulkarni AV, MacAulay N, Robinson S, et al. Paediatric hydrocephalus. Nat Rev Dis Primers. 2024 May 16;10(1):35.
2. Hochstetler A, Raskin J, Blazer-Yost BL. Hydrocephalus: historical analysis and considerations for treatment. Eur J Med Res. 2022 Sept 1;27(1):168.
3. Dewan MC, Rattani A, Mekary R, Glancz LJ, Yunusa I, Baticulon RE, et al. Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. Journal of Neurosurgery. 2019 Apr;130(4):1065–79.
4. Albalkhi I, Garatli S, Helal B, Saleh T, AlRamadan AH, Warf BC. Morbidity and etiology-based success rate of combined endoscopic ventriculostomy and choroid plexus cauterization: a systematic review and meta-analysis of 1918 infants. Neurosurg Rev. 2023 July 19;46(1):180.
5. Zimmerman K, May B, Barnes K, Arynchyna A, Alford EN, Chagoya G, et al. Hydrocephalus-related quality of life as assessed by children and their caregivers. Journal of Neurosurgery: Pediatrics. 2020 Oct;26(4):353–63.
6. Whitelaw A, Evans D, Carter M, Thoresen M, Wroblewska J, Mandera M, et al. Randomized Clinical Trial of Prevention of Hydrocephalus After Intraventricular Hemorrhage in Preterm Infants: Brain-Washing Versus Tapping Fluid. Pediatrics. 2007 May 1;119(5):e1071–8.
7. Malheiros JA, Trivelato FP, Oliveira MM, Gusmão S, Cochrane DD, Steinbok P. Endoscopic Choroid Plexus Cauterization Versus Ventriculoperitoneal Shunt for Hydranencephaly and Near Hydranencephaly: A Prospective Study. Neurosurgery. 2010 Mar;66(3):459–64.
8. Kestle JRW, Drake JM, Cochrane DD, Milner R, Walker ML, Abbott R, et al. Lack of benefit of endoscopic ventriculoperitoneal shunt insertion: a multicenter randomized trial. Journal of Neurosurgery. 2003 Feb;98(2):284–90.
9. Kulkarni AV, Sgouros S, Constantini S. International Infant Hydrocephalus Study: initial results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus. Childs Nerv Syst. 2016 June;32(6):1039–48.
10. Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, et al. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. N Engl J Med. 2017 Dec 21;377(25):2456–64.
11. Kulkarni AV, Sgouros S, Leitner Y, Constantini S. International Infant Hydrocephalus Study (IIHS): 5-year health outcome results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus. Childs Nerv Syst. 2018 Dec;34(12):2391–7.
12. Lane JR, Ssentongo P, Peterson MR, Harper JR, Mbabazi-Kabachelor E, Mugamba J, et al. Preoperative risk and postoperative outcome from subdural fluid collections in African infants with postinfectious hydrocephalus. Journal of Neurosurgery: Pediatrics. 2022 Jan 1;29(1):31–9.
13. Schiff SJ, Kulkarni AV, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, et al. Brain growth after surgical treatment for infant postinfectious hydrocephalus in Sub-Saharan Africa: 2-year results of a randomized trial. Journal of Neurosurgery: Pediatrics. 2021 Sept;28(3):326–34.
14. Punchak M, Mbabazi Kabachelor E, Ogwal M, Nalule E, Nalwoga J, Ssenyonga P, et al. The Incidence of Postoperative Seizures Following Treatment of Postinfectious Hydrocephalus in Ugandan Infants: A Post Hoc Comparison of Endoscopic Treatment vs Shunt Placement in a Randomized Controlled Trial. Neurosurg. 2019 Oct;85(4):E714–21.
15. Haq NU, Ishaq M, Jalal A. Outcome Comparison of Endoscopic Third Ventriculostomy Versus Ventriculoperitoneal Shunt in Obstructive Hydrocephalus. PJMHS. 2022 Feb 26;16(2):956–8.
16. Ahmed Simair I, Jawad Ali H, Qureshi A, Salah-ud-Din T. Outcome Comparison of Endoscopic Third Ventriculostomy versus Ventriculoperitoneal Shunt in Obstructive Hydrocephalus. Pak J Neurol Surg. 2021 Sept 30;25(3):324–30.
17. Arynchyna-Smith A, Rozzelle CJ, Jensen H, Reeder RW, Kulkarni AV, Pollack IF, et al. Endoscopic third ventriculostomy revision after failure of initial endoscopic third ventriculostomy and choroid plexus cauterization. Journal of Neurosurgery: Pediatrics. 2022 July 1;30(1):8–17.
18. Dewan MC, Lim J, Gannon SR, Heaner D, Davis MC, Vaughn B, et al. Comparison of hydrocephalus metrics between infants successfully treated with endoscopic third ventriculostomy with choroid plexus cauterization and those treated with a ventriculoperitoneal shunt: a multicenter matched-cohort analysis. Journal of Neurosurgery: Pediatrics. 2018 Apr;21(4):339–45.
19. Warf BC. Congenital idiopathic hydrocephalus of infancy: the results of treatment by endoscopic third ventriculostomy with or without choroid plexus cauterization and suggestions for how it works. Childs Nerv Syst. 2013 June;29(6):935–40.
20. Chamiraju P, Bhatia S, Sandberg DI, Ragheb J. Endoscopic third ventriculostomy and choroid plexus cauterization in posthemorrhagic hydrocephalus of prematurity: Clinical article. PED. 2014 Apr;13(4):433–9.
21. Warf BC, Campbell JW. Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants: Clinical article. PED. 2008 Nov;2(5):310–6.
22. Prajapati HP, Ansari MA, Jaiswal M. Comparative Outcome Analysis of Endoscopic Third Ventriculostomy and Ventriculoperitoneal Shunt Surgery in Pediatric Hydrocephalus: An Experience of a Tertiary Care Center. Asian J Neurosurg. 2022 June;17(02):227–34.
23. Lodha K, Jaiswal G, Gupta T, Parashar V, Singh Y. Endoscopic third ventriculostomy for hydrocephalus in infants: A single-center experience. Asian J Neurosurg. 2020 June;15(02):302–5.
24. Choudhary A, Sobti S, Zambre S, Bhaskar S. Endoscopic third ventriculostomy in failed ventriculoperitoneal shunt in pediatric population. Asian J Neurosurg. 2020 Dec;15(04):937–40.
25. Dewan MC, Lim J, Gannon SR, Heaner D, Davis MC, Vaughn B, et al. Comparison of hydrocephalus metrics between infants successfully treated with endoscopic third ventriculostomy with choroid plexus cauterization and those treated with a ventriculoperitoneal shunt: a multicenter matched-cohort analysis. Journal of Neurosurgery: Pediatrics. 2018 Apr;21(4):339–45.
26. Diallo O, Dama M, Konan L, Coulibaly O, Sissoko D, Maiga AH. Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization in Infantile Hydrocephalus: An Experience from Mali. Pediatr Neurosurg. 2023;58(1):38–44.
27. Haizel-Cobbina J, Coompson C, Addy S, Darko K, Obiri-Yeboah D, Ampofo K, et al. Pediatric hydrocephalus management at a major neurosurgical referral center in Kumasi, Ghana. Childs Nerv Syst. 2025 Dec;41(1):299.
28. Pindrik J, Rocque BG, Arynchyna AA, Johnston JM, Rozzelle CJ. Radiographic markers of clinical outcomes after endoscopic third ventriculostomy with choroid plexus cauterization: cerebrospinal fluid turbulence and choroid plexus visualization. PED. 2016 Sept;18(3):287–95.
29. Navaei A, Hanaei S, Habibi Z, Jouibari M, Heidari V, Naderi S, et al. Controlled trial to compare therapeutic efficacy of endoscopic third ventriculostomy plus choroid plexus cauterization with ventriculoperitoneal shunt in infants with obstructive hydrocephalus. Asian J Neurosurg. 2018 Dec;13(04):1042–7.
30. Stone SSD, Warf BC. Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment for infant hydrocephalus: a prospective North American series: Clinical article. PED. 2014 Nov;14(5):439–46.
31. Oi S, Di Rocco C. Proposal of “evolution theory in cerebrospinal fluid dynamics” and minor pathway hydrocephalus in developing immature brain. Childs Nerv Syst. 2006 July;22(7):662–9.
32. Fame RM, Cortés‐Campos C, Sive HL. Brain Ventricular System and Cerebrospinal Fluid Development and Function: Light at the End of the Tube: A Primer with Latest Insights. BioEssays. 2020 Mar;42(3):1900186.
33. Chau KF, Springel MW, Broadbelt KG, Park H yeon, Topal S, Lun MP, et al. Progressive Differentiation and Instructive Capacities of Amniotic Fluid and Cerebrospinal Fluid Proteomes following Neural Tube Closure. Developmental Cell. 2015 Dec;35(6):789–802.
34. Saunders NR, Dziegielewska KM, Fame RM, Lehtinen MK, Liddelow SA. The choroid plexus: a missing link in our understanding of brain development and function. Physiological Reviews. 2023 Jan 1;103(1):919–56.
35. Cinalli G, Spennato P, Savarese L, Ruggiero C, Aliberti F, Cuomo L, et al. Endoscopic aqueductoplasty and placement of a stent in the cerebral aqueduct in the management of isolated fourth ventricle in children. Journal of Neurosurgery: Pediatrics. 2006 Jan;104(1):21–7.
36. Schroeder HWS, Oertel J, Gaab MR. Endoscopic aqueductoplasty in the treatment of aqueductal stenosis. Childs Nerv Syst. 2004 Nov;20(11–12):821–7.
37. Fritsch MJ, Schroeder HWS. Endoscopic Aqueductoplasty and Stenting. World Neurosurgery. 2013 Feb;79(2):S20.e15-S20.e18.
38. Encarnación-Santos D, Chmutin G, Chmutin E, Bozkurt I, Chaurasia B. Management of hydrocephalus after cerebellar pilocytic astrocytoma in a pediatric patient: case report and literature review. OncoReview. 2025 May 28;14(4(56)):88–92.
39. Encarnacion D, Chmutin G, Chaurasia B, Bozkurt I. Hundred Pediatric Cases Treated for Chiari Type II Malformation with Hydrocephalus and Myelomeningocele. Asian J Neurosurg. 2023 June;18(02):258–64.
40. Chen HH, Riva-Cambrin J, Brockmeyer DL, Walker ML, Kestle JRW. Shunt failure due to intracranial migration of BioGlide ventricular catheters: Clinical article. PED. 2011 Apr;7(4):408–12.
41. Browd SR, Ragel BT, Gottfried ON, Kestle JRW. Failure of Cerebrospinal Fluid Shunts: Part I: Obstruction and Mechanical Failure. Pediatric Neurology. 2006 Feb;34(2):83–92.
42. Browd SR, Gottfried ON, Ragel BT, Kestle JRW. Failure of Cerebrospinal Fluid Shunts: Part II: Overdrainage, Loculation, and Abdominal Complications. Pediatric Neurology. 2006 Mar;34(3):171–6.
43. Anderson, R. C. E., H. J. L. Garton, and J. R. W. Kestle. "TREATMENT OF HYDROCEPHALUS WITH SHUNTS. IN: ALBRIGHT AL, POLLACK IF, ADELSON PD, EDS. PRINCIPLES AND PRACTICE OF PEDIATRIC NEUROSURGERY." (2008): 109-130.
44. Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, et al. Long-Term Follow-Up Data from the Shunt Design Trial. Pediatr Neurosurg. 2000;33(5):230–6.
45. Riva-Cambrin J, Kestle JRW, Holubkov R, Butler J, Kulkarni AV, Drake J, et al. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. PED. 2016 Apr;17(4):382–90.
46. Tuli S, O’Hayon B, Drake J, Clarke M, Kestle J. Change in Ventricular Size and Effect of Ventricular Catheter Placement in Pediatric Patients with Shunted Hydrocephalus. Neurosurgery. 1999 Dec;45(6):1329–35.
47. Chumas PD, Armstrong DC, Drake JM, Kulkarni AV, Hoffman HJ, Humphreys RP, et al. Tonsillar herniation: the rule rather than the exception after lumboperitoneal shunting in the pediatric population. Journal of Neurosurgery. 1993 Apr;78(4):568–73.
48. Sood S, Barrett RJ, Powell T, Ham SD. The role of lumbar shunts in the management of slit ventricles: does the slit-ventricle syndrome exist? Journal of Neurosurgery: Pediatrics. 2005 Aug;103(2):119–23.
49. Ismail AA, Taha AN, Badr HI, Zaher A, Elbaz SA, Khalil AF. Comparative study between ventriculosubgaleal shunt and external ventricular drain for management of post infective hydrocephalus among pediatrics. Childs Nerv Syst. 2024 June;40(6):1771–6.
50. Fulmer BB, Grabb PA, Oakes WJ, Mapstone TB. Neonatal Ventriculosubgaleal Shunts. Neurosurgery. 2000 July 1;47(1):80–4.
51. Tubbs RS, Smyth MD, Wellons Iii JC, Blount JP, Grabb PA, Oakes WJ. Life Expectancy of Ventriculosubgaleal Shunt Revisions. Pediatr Neurosurg. 2003;38(5):244–6.
52. Drapkin AJ, Levine ME, Yang WC. Ventriculo-subgaleal shunt: Evaluation by computed tomography. Acta neurochir. 1980 Dec;55(1–2):107–15.
53. Hersh DS, Dave P, Weeks M, Hankinson TC, Karimian B, Staulcup S, et al. Converting Pediatric Patients and Young Adults From a Shunt to a Third Ventriculostomy: A Multicenter Evaluation. Neurosurg. 2020 Aug;87(2):285–93.
54. Chan DYC, Tsang ACO, Ho WWS, Cheng KKF, Li LF, Tsang FCP, et al. Emergency endoscopic third ventriculostomy for blocked shunts? Univariate and multivariate analysis of independent predictors for failure. Journal of Neurosurgery. 2019 Oct;131(4):1004–10.
55. Furtado LMF, Da Costa Val Filho JA, Holliday JB, Da Silva Costa J, De Matos MA, Nascimento VAM, et al. Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure. Childs Nerv Syst. 2020 Dec;36(12):3047–52.
56. Sharma R, Sharma R, Tandon V, Phalak M, Garg K, Singh M, et al. Is Endoscopic Third Ventriculostomy a Feasible Option or Ventriculoperitoneal Shunt a Safer Bet for the Treatment of Posttraumatic Hydrocephalus? A Gap Time Model-based Algorithm. Neurol India. 2020;68(5):1125.
57. Krejčí O, Krejčí T, Mrůzek M, Večeřa Z, Šalounová D, Lipina R. Hydrocephalus Caused by Primary Fourth Ventricle Outlet Obstruction: Our Experience and Literature Review. World Neurosurgery. 2021 Apr;148:e425–35.
58. Konar S, Kandregula S, Sashidhar A, Prabhuraj AR, Saini J, Shukla D, et al. Endoscopic intervention for intraventricular neurocysticercal cyst: Challenges and outcome analysis from a single institute experience. Clinical Neurology and Neurosurgery. 2020 Nov;198:106179.
59. Husain M, Rastogi M, Jha DK, Husain N, Gupta RK. ENDOSCOPIC TRANSAQUEDUCTAL REMOVAL OF FOURTH VENTRICULAR NEUROCYSTICERCOSIS WITH AN ANGIOGRAPHIC CATHETER. Operative Neurosurgery. 2007 Apr;60(4):249–54.
60. Suri A, Goel RK, Ahmad FU, Vellimana AK, Sharma BS, Mahapatra AK. Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth ventricular neurocysticercosis: a series of 13 cases and a review. PED. 2008 Jan;1(1):35–9.
61. Samadian M, Maloumeh EN, Shiravand S, Ebrahimzadeh K, Sharifi G, Mousavinejad A, et al. Pineal region tumors: Long-term results of endoscopic third ventriculostomy and concurrent tumor biopsy with a single entry approach in a series of 64 cases. Clinical Neurology and Neurosurgery. 2019 Sept;184:105418.
62. Chibbaro S, Di Rocco F, Makiese O, Reiss A, Poczos P, Mirone G, et al. Neuroendoscopic management of posterior third ventricle and pineal region tumors: technique, limitation, and possible complication avoidance. Neurosurg Rev. 2012 July;35(3):331–40.
63. Brusius CV, Bianchin MM, Mira JM, Frigeri T, Kruger M, Grudtner MC, et al. Single Burr-Hole Extended Transforaminal Approach for Concurrent Endoscopic Surgery in the Third Ventricle Posterior to the Foramen of Monro and Ventriculostomy: Clinical Series and Planning Steps. World Neurosurgery. 2021 June;150:e1–11.
64. Torres-Corzo J, Vinas-Rios JM, Viana Rojas JA, Cervantes D, Sánchez-Aguilar M, Chalita-Williams JC, et al. Endoscopic transventricular exploration with biopsy of the basal cisterns and the role of endoscopic third ventriculostomy in patients suffering with basal cistern meningitis and consecutive hydrocephalus. Neurological Research. 2016 July 2;38(7):593–9.
65. Ogiwara T, Suzuki Y, Hasegawa T, Nakamura T, Fujii Y, Hanaoka Y, et al. Tailor-Made Endoscopic Surgical Strategy for Severe Intraventricular Hemorrhage with Obstructive Hydrocephalus. World Neurosurgery. 2021 June;150:e771–6.
66. Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A. Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol. 2007 Dec;7(1):1.
67. Yadav YR, Jaiswal S, Adam N, Basoor A, Jain G. Endoscopic third ventriculostomy in infants. Neurol India. 2006 June;54(2):161–3
68. Massimi L, Pennisi G, Frassanito P, Tamburrini G, Di Rocco C, Caldarelli M. Chiari type I and hydrocephalus